These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

148 related articles for article (PubMed ID: 18569785)

  • 21. Synthesis of gemcitabine triphosphate (dFdCTP) as a tris(triethylammonium) salt.
    Risbood PA; Kane CT; Hossain MT; Vadapalli S; Chadda SK
    Bioorg Med Chem Lett; 2008 May; 18(9):2957-8. PubMed ID: 18396042
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Cell cycle effects of gemcitabine.
    Cappella P; Tomasoni D; Faretta M; Lupi M; Montalenti F; Viale F; Banzato F; D'Incalci M; Ubezio P
    Int J Cancer; 2001 Aug; 93(3):401-8. PubMed ID: 11433406
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Nucleosides and nucleotides. 180. Synthesis and antitumor activity of nucleosides that have a hydroxylamino group instead of a hydroxyl group at the 2'- or 3'-position of the sugar moiety.
    Ogawa A; Tanaka M; Sasaki T; Matsuda A
    J Med Chem; 1998 Dec; 41(25):5094-107. PubMed ID: 9836625
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gemcitabine-based therapy for pancreatic cancer using the squalenoyl nucleoside monophosphate nanoassemblies.
    Maksimenko A; Caron J; Mougin J; Desmaële D; Couvreur P
    Int J Pharm; 2015 Mar; 482(1-2):38-46. PubMed ID: 25448549
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Nucleoside-catabolizing enzymes in mycoplasma-infected tumor cell cultures compromise the cytostatic activity of the anticancer drug gemcitabine.
    Vande Voorde J; Sabuncuoğlu S; Noppen S; Hofer A; Ranjbarian F; Fieuws S; Balzarini J; Liekens S
    J Biol Chem; 2014 May; 289(19):13054-65. PubMed ID: 24668817
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cellular pharmacology of gemcitabine.
    Mini E; Nobili S; Caciagli B; Landini I; Mazzei T
    Ann Oncol; 2006 May; 17 Suppl 5():v7-12. PubMed ID: 16807468
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effects of gemcitabine and araC on in vitro DNA synthesis mediated by the human breast cell DNA synthesome.
    Jiang HY; Hickey RJ; Abdel-Aziz W; Malkas LH
    Cancer Chemother Pharmacol; 2000; 45(4):320-8. PubMed ID: 10755321
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Synthesis and antiviral activity assay of novel (E)-3',5'-diamino-5-(2-bromovinyl)-2',3',5'-trideoxyuridine.
    Lavandera I; Fernández S; Ferrero M; De Clercq E; Gotor V
    Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):833-6. PubMed ID: 14565290
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Interaction of an amphiphilic squalenoyl prodrug of gemcitabine with cellular membranes.
    Bildstein L; Pili B; Marsaud V; Wack S; Meneau F; Lepêtre-Mouelhi S; Desmaële D; Bourgaux C; Couvreur P; Dubernet C
    Eur J Pharm Biopharm; 2011 Nov; 79(3):612-20. PubMed ID: 21784150
    [TBL] [Abstract][Full Text] [Related]  

  • 30. pH and singlet oxygen dual-responsive GEM prodrug micelles for efficient combination therapy of chemotherapy and photodynamic therapy.
    Chen L; Zhuang W; Hu C; Yu T; Su X; Liang Z; Li G; Wang Y
    J Mater Chem B; 2020 Jul; 8(26):5645-5654. PubMed ID: 32538389
    [TBL] [Abstract][Full Text] [Related]  

  • 31. In vitro and in vivo anti-tumor activities of a gemcitabine derivative carried by nanoparticles.
    Sloat BR; Sandoval MA; Li D; Chung WG; Lansakara-P DS; Proteau PJ; Kiguchi K; DiGiovanni J; Cui Z
    Int J Pharm; 2011 May; 409(1-2):278-88. PubMed ID: 21371545
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of a UCMK/dCK fusion enzyme for gemcitabine-mediated cytotoxicity.
    Johnson AJ; Brown MN; Black ME
    Biochem Biophys Res Commun; 2011 Dec; 416(1-2):199-204. PubMed ID: 22093835
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Preparation, physicochemical characterization and cytotoxicity in vitro of gemcitabine-loaded PEG-PDLLA nanovesicles.
    Jia L; Zheng JJ; Jiang SM; Huang KH
    World J Gastroenterol; 2010 Feb; 16(8):1008-13. PubMed ID: 20180242
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Synthesis and biological evaluation of oral prodrugs based on the structure of gemcitabine.
    Zhao C; Xue X; Li G; Sun C; Sun C; Qu X; Li W
    Chem Biol Drug Des; 2012 Sep; 80(3):479-88. PubMed ID: 22642666
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumoral activity of PEG-gemcitabine prodrugs targeted by folic acid.
    Pasut G; Canal F; Dalla Via L; Arpicco S; Veronese FM; Schiavon O
    J Control Release; 2008 May; 127(3):239-48. PubMed ID: 18346806
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Enhanced Antitumor Activity of Monophosphate Ester Prodrugs of Gemcitabine: In Vitro and In Vivo Evaluation.
    Qi H; Lu J; Li J; Wang M; Xu Y; Wang Y; Zhang H
    J Pharm Sci; 2016 Sep; 105(9):2966-2973. PubMed ID: 26994559
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drosophila melanogaster deoxyribonucleoside kinase activates gemcitabine.
    Knecht W; Mikkelsen NE; Clausen AR; Willer M; Eklund H; Gojković Z; Piskur J
    Biochem Biophys Res Commun; 2009 May; 382(2):430-3. PubMed ID: 19285960
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Gemcitabine: metabolism, mechanisms of action, and self-potentiation.
    Plunkett W; Huang P; Xu YZ; Heinemann V; Grunewald R; Gandhi V
    Semin Oncol; 1995 Aug; 22(4 Suppl 11):3-10. PubMed ID: 7481842
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Synthesis and antiviral properties of (E)-5-(2-bromovinyl)-2'-deoxycytidine-related compounds.
    Jones AS; Sayers JR; Walker RT; De Clercq E
    J Med Chem; 1988 Jan; 31(1):268-71. PubMed ID: 2826786
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantification of gemcitabine incorporation into human DNA by LC/MS/MS as a surrogate measure for target engagement.
    Wickremsinhe ER; Lutzke BS; Jones BR; Schultz GA; Freeman AB; Pratt SE; Bones AM; Ackermann BL
    Anal Chem; 2010 Aug; 82(15):6576-83. PubMed ID: 20698580
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.